March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
The Effect Of L-arginine For The Treatment Of The Rodent Model Of Nonarteritic Ischemic Optic Neuropathy (r-naion)
Author Affiliations & Notes
  • Tomoyuki Maekubo
    Ophthalmology, University of Miyazaki, Miyazaki City, Japan
  • Hideki Chuman
    Ophthalmology, University of Miyazaki, Miyazaki City, Japan
  • Michitaka Ishiai
    Ophthalmology, University of Miyazaki, Miyazaki City, Japan
  • Yuu Kodama
    Ophthalmology, University of Miyazaki, Miyazaki City, Japan
  • Takako Oosako
    Ophthalmology, University of Miyazaki, Miyazaki City, Japan
  • Takako Sugimoto
    Ophthalmology, University of Miyazaki, Miyazaki City, Japan
  • Naoko Kawano
    Ophthalmology, University of Miyazaki, Miyazaki City, Japan
  • Nobuhisa Nao-i
    Ophthalmology, University of Miyazaki, Miyazaki City, Japan
  • Footnotes
    Commercial Relationships  Tomoyuki Maekubo, None; Hideki Chuman, None; Michitaka Ishiai, None; Yuu Kodama, None; Takako Oosako, None; Takako Sugimoto, None; Naoko Kawano, None; Nobuhisa Nao-i, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2978. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tomoyuki Maekubo, Hideki Chuman, Michitaka Ishiai, Yuu Kodama, Takako Oosako, Takako Sugimoto, Naoko Kawano, Nobuhisa Nao-i; The Effect Of L-arginine For The Treatment Of The Rodent Model Of Nonarteritic Ischemic Optic Neuropathy (r-naion). Invest. Ophthalmol. Vis. Sci. 2012;53(14):2978.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the effectiveness of L-arginine for the treatment of r-NAION using the optical coherent tomography (OCT). L-arginine, a NO substrate, is a non-toxic amino acid and it has been known to be clinically useful as a growth hormone releasing agent in pediatrics. It is the precursor of the synthesis of Nitric Oxide (NO), a labile free radical, by NO synthese. It has been reported that infusion of L-arginine has produced NO in the rabbit eye and have made the ciliary artery dilate. Thus, L-arginine could have a potential role to improve the optic disc edema efficiently and reduce the following neuronal damage.

Methods: : To compare the effectiveness of L-arginine for the degree of disc swelling with rNAION control (no treatment, n=7), L-Arginine (500mg/kg, twice a day) was administered intravenously for 7days to the rNAION (n=7), and we measured the inner retinal thickness (from the internal limiting membrane to the inner plexiform layer) using OCT. The OCT was measured before and after the induction at 1st, 3rd, 7th, 14th, 28th, and 56th day.

Results: : In the L-arginine treatment group, the degree of disc swelling was significantly smaller than the control group at 1st and 3rd day (arginine vs control; 116.32±9.74 (SD) vs 122.34±8.09μm, 108.82±5.47 vs 116.27±8.67, respectively, p<0.05). In the L-arginine treatment group, the preservation of inner retinal thickness was significantly larger than the control group at 7th and 14th day (arginine vs control; 98.55±6.96 (SD) vs 91.20±4.58μm, 76.87±7.78 vs 71.38 ±7.60, respectively, p<0.05). However, the late stage inner retinal thickness was similar in both group at 28thand 56th day (arginine vs control; 65.53±5.63 (SD) vs 65.95±2.78μm, 62.04±7.69 vs 60.15±6.67, respectively, p=0.32,p=0.21 ).

Conclusions: : In the treatment of L-arginine, the disc swelling of rNAION become milder and slower to reduce the inner retinal thickness. L-arginine does not have the protective effect for the long-standing decrease of inner retinal thickness.

Keywords: neuro-ophthalmology: optic nerve • ischemia • nerve fiber layer 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×